Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein

Biotechnology Letters

Volumn 33, Issue 6, 2011, Pages 1169-1175

  Rodríguez Díaz, Jesús ^a,b   Montava, Rebeca ^a   Viana, Rosa ^b   Buesa, Javier ^a   Pérez Martínez, Gaspar ^b   Monedero, Vicente ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Cell wall; Lactic acid bacteria; Rotavirus; Vaccine

Indexed keywords

ALANINE RACEMASE; CELL-WALL; CELL-WALL COMPONENTS; DELIVERY VEHICLE; EXTRACELLULAR; IMMUNE RESPONSE; LACTIC ACID BACTERIA; LACTOCOCCUS LACTIS; MOUSE MODELS; MUCOSAL IMMUNE RESPONSE; ORAL ADMINISTRATION; RECOMBINANT LACTOCOCCUS; RECOMBINANT STRAINS; ROTAVIRUSES; WILD TYPES;

AMINO ACIDS; ANTIGENS; BACTERIOLOGY; BODY FLUIDS; ENZYME ACTIVITY; IMMUNIZATION; IMMUNOLOGY; LACTIC ACID; PROTEINS;

BIOSYNTHESIS;

ALANINE RACEMASE; IMMUNOGLOBULIN A; NS35 PROTEIN, ROTAVIRUS; RECOMBINANT VACCINE; RNA BINDING PROTEIN; ROTAVIRUS VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BIOTECHNOLOGY; FEMALE; GENE VECTOR; GENETICS; IMMUNOLOGY; LACTOCOCCUS LACTIS; METABOLISM; MOUSE; MUCOSAL IMMUNITY; MUTATION; NUCLEOTIDE SEQUENCE; ORAL DRUG ADMINISTRATION; PLASMID; ROTAVIRUS; ROTAVIRUS INFECTION;

ADMINISTRATION, ORAL; ALANINE RACEMASE; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; BIOTECHNOLOGY; FEMALE; GENETIC VECTORS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; LACTOCOCCUS LACTIS; MICE; MICE, INBRED BALB C; MUTATION; PLASMIDS; RNA-BINDING PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, SYNTHETIC; VIRAL NONSTRUCTURAL PROTEINS;

BACTERIA (MICROORGANISMS); LACTOCOCCUS LACTIS; MUS; ROTAVIRUS;

EID: 79955936699     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-011-0551-6     Document Type: Article

References (22)

1. Areas AP, Oliveira ML, Ramos CR, Sbrogio-Almeida ME, Raw I, Ho PL (2002) Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6× His-tagged protein in Escherichia coli. Protein Expr Purif 25: 481-487.
2. Bermudez-Humaran LG (2009) Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins. Hum Vaccin 5: 264-267.
3. Garcia-Diaz A, Lopez-Andujar P, Rodriguez Diaz J, Montava R, Torres Barcelo C, Ribes JM, Buesa J (2004) Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies. Vaccine 23: 489-498.
4. Gil MT, de Souza CO, Asensi M, Buesa J (2000) Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein. Viral Immunol 13: 187-200.
5. Gil MT, Perez-Arellano I, Buesa J, Perez-Martinez G (2001) Secretion of the rotavirus VP8* protein in Lactococcus lactis. FEMS Microbiol Lett 203: 269-274.
6. Grangette C, Muller-Alouf H, Geoffroy M, Goudercourt D, Turneer M, Mercenier A (2002) Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 20: 3304-3309.
7. Grangette C, Muller-Alouf H, Hols P, Goudercourt D, Delcour J, Turneer M, Mercenier A (2004) Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infect Immun 72: 2731-2737.
8. Hols P, Kleerebezem M, Schanck AN, Ferain T, Hugenholtz J, Delcour J, de Vos WM (1999) Conversion of Lactococcus lactis from homolactic to homoalanine fermentation through metabolic engineering. Nat Biotechnol 17: 588-592.
9. Kapikian AZ (2001) A rotavirus vaccine for prevention of severe diarrhoea of infants and young children: development, utilization and withdrawal. Novartis Found Symp 238: 153-171, discussion 171-159.
10. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI (2003) Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9: 565-572.
11. Parashar UD, Burton A, Lanata C, Boschi-Pinto C, Shibuya K, Steele D, Birmingham M, Glass RI (2009) Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 200(1): S9-S15.
12. Qiao X, Li G, Wang X, Li X, Liu M, Li Y (2009) Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice. BMC Microbiol 9: 249.
13. Robinson K, Chamberlain LM, Lopez MC, Rush CM, Marcotte H, Le Page RW, Wells JM (2004) Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. Infect Immun 72: 2753-2761.
14. Rottiers P, De Smedt T, Steidler L (2009) Modulation of gut-associated lymphoid tissue functions with genetically modified Lactococcus lactis. Int Rev Immunol 28: 465-486.
15. Ruggeri FM, Greenberg HB (1991) Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol 65: 2211-2219.
16. Schotte L, Steidler L, Vandekerckhove J, Remaut E (2000) Secretion of biologically active murine interleukin-10 by Lactococcus lactis. Enzym Microb Technol 27: 761-765.
17. Steen A, Palumbo E, Deghorain M, Cocconcelli PS, Delcour J, Kuipers OP, Kok J, Buist G, Hols P (2005) Autolysis of Lactococcus lactis is increased upon d-alanine depletion of peptidoglycan and lipoteichoic acids. J Bacteriol 187: 114-124.
18. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289: 1352-1355.
19. Vandenbroucke K, Hans W, van Huysse J, Neirynck S, Demetter P, Remaut E, Rottiers P, Steidler L (2004) Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127: 502-513.
20. Ward RL (2003) Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 16: 17-24.
21. Waterfield NR, Le Page RW, Wilson PW, Wells JM (1995) The isolation of lactococcal promoters and their use in investigating bacterial luciferase synthesis in Lactococcus lactis. Gene 165: 9-15.
22. Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6: 349-362.